Tenet Healthcare (THC) 2024 Wells Fargo Healthcare Conference summary

Strategic transformation and portfolio management

• Multi-year focus on deleveraging, asset divestitures, and ambulatory business growth has positioned the organization for greater financial flexibility and stability, enabling increased investment in growth areas over the next several years.

• Asset sales were opportunistic, based on portfolio quality and strategic value, with proceeds used to materially reduce leverage and improve the balance sheet.

• The current hospital portfolio is considered stronger and more investable, supporting both organic and inorganic growth strategies.

• Long-term investments in acute care hospitals are underway in growth markets like San Antonio, Charlotte, and Palm Beach, with confidence in profitable expansion.

• Capital expenditure flexibility has increased, allowing for responsive investment as market demands shift.

Operational performance and demand environment

• Strong inpatient volume growth is driven by a deliberate focus on higher acuity admissions, intensive care, and procedural services, improving profitability and reducing contract labor needs.

• The demand environment is robust, with expectations of post-COVID demand stimulus continuing through 2025, after which operational efficiency will be key to earnings growth.

• Cost management discipline is now embedded in operations, supporting consistent performance and talent development.

• Hospital EBITDA is expected to show sequential improvement, with portfolio changes influencing historical comparisons.

• Wage inflation and labor costs have stabilized, allowing for targeted investments in capacity and growth.

Ambulatory and ASC (USPI) growth

• USPI has demonstrated strong volume recovery and organic growth, outperforming guidance and raising earnings targets mid-year.

• The platform’s attractiveness to physician partners is rooted in profitability, operational excellence, and the ability to expand and diversify ASC offerings.

• The shift of procedures, such as total joint surgeries, from inpatient to outpatient and ASC settings is accelerating, with significant cost and service benefits.

• Acquisition discipline remains high, with a focus on high-quality, margin-rich assets and an increasing emphasis on de novo and early-stage development.

• Annual capital deployment for ASC acquisitions is expected to remain disciplined, despite improved balance sheet flexibility.